1137 related articles for article (PubMed ID: 10383153)
21. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
22. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
23. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J; Cascorbi I; Kerb R; Roots I
Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
[TBL] [Abstract][Full Text] [Related]
26. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
28. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
30. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
31. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
35. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
36. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
[TBL] [Abstract][Full Text] [Related]
37. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
38. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
[TBL] [Abstract][Full Text] [Related]
39. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
40. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
